Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population

Journal of Pineal Research

Volumn 39, Issue 2, 2005, Pages 201-205

  Ha, Eunyoung ^a   Choe, Bong Keun ^a   Jung, Kyung Hee ^a   Yoon, Seo Hyun ^a   Park, Hae Jeong ^a   Park, Hun Kuk ^a   Yim, Sung Vin ^a   Chung, Joo Ho ^a   Bae, Hyun Su ^b   Nam, Min ^c   Baik, Hyung Hwan ^a   Hong, Seung Jae ^d,e  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d CHA University   (South Korea)

^e Bundang CHA Hospital   (South Korea)

Author keywords

Melatonin; Melatonin receptor type 1B; Polymorphism; Rheumatoid arthritis

Indexed keywords

ANTIINFLAMMATORY AGENT; MELATONIN; MELATONIN 1 RECEPTOR; RESTRICTION ENDONUCLEASE; RHEUMATOID FACTOR;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HUMAN; INFLAMMATORY DISEASE; KOREA; MAJOR CLINICAL STUDY; MALE; MOLECULAR PHYLOGENY; POLYMERASE CHAIN REACTION; POPULATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, MELATONIN; RHEUMATOID FACTOR;

EID: 23744495865     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2005.00237.x     Document Type: Article

References (37)

1. REITER RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 2003; 17:273-285.
2. FIRESTEIN GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423:356-361.
3. REITER RJ, CALVO JR, KARBOWNIK M et al. Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 2000; 917:376-386.
4. JAWOREK J, LEJA-SZPAK A, BONIOR J et al. Protective effect of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J Pineal Res 2003; 34:40-52.
5. NAVA M, QUIROZ Y, VAZIRI N et al. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2003; 284:F447-F454.
6. POZO D, REITER RJ, CALVO JR et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 85:430-432.
7. CUZZOCREA S, ZINGARELLI B, HAKE P et al. Anti-inflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 1998; 24:450-459.
8. CUZZOCREA S, COSTANTINO G, MAZZON E et al. Regulation of prostaglandin production in carrageenan-induced pleurisy by melatonin. J Pineal Res 1999; 27:9-14.
9. MOHAN N, SADEGHI K, REITER RJ et al. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem Mol Biol Int 1995; 37:1063-1070.
10. GILAD E, WONG HR, ZINGARELLI B et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J 1998; 12:685-693.
11. LEZOUVALC'H F, SPARAPANI M, BEHL C. N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppresses the activity of the transcription factor NFκB. J Pineal Res 1998; 24:168-178.
12. JIMENEZ-CALIANI AJ, JIMENEZ-JORGE S, MOLINERO P et al. Dual effect of melatonin as pro-inflammatory and antioxidant in collagen-induced arthritis in rats. J Pineal Res 2005; 38:93-99.
13. SUTHERLAND ER, MARTIN RJ, ELLISON MC et al. Immunomodulatory effects of melatonin in asthma. Am J Respir Crit Care Med 2002; 166:1055-1061.
14. CUTOLO M, MASI AT. Circadian rhythms and arthritis. Rheum Dis Clin North Am 2005; 31:115-129.
15. CARRILLO VICO A, CALVO JR, ABREU P et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 2004; 18:537-539.
16. CONTI A, CONCONI S, HERTENS E et al. Evidence for melatonin synthesis in mouse and human bone marrow cells. J Pineal Res 2000; 28:193-202.
17. TAN DX, MANCHESTER LC, REITER RJ et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim Biophys Acta 1999; 1472:206-214.
18. MAESTRONI GJ, CARDINALI DP, ESQUIFINO AI et al. Does melatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 2005; 158:106-111.
19. WEST SK, OOSTHUIZEN JM. Melatonin levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 1992; 3:33-40.
20. PETROVSKY N, HARRISON LC. The chronobiology of human cytokine production. Int Rev Immunol 1998; 16:635-649.
21. SULLI A, MAESTRONI GJ, VILLAGGIO B et al. Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 2002; 966:276-283.
22. MAESTRONI GJ, SULLI A, PIZZORNI C et al. Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 2002; 966:271-275.
23. CARDINALI DP, GARCIA AP, CANO P et al. Melatonin role in experimental arthritis. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4:1-10.
24. COLLINS FS, GREEN ED, GUTTMACHER AE et al. A vision for the future of genomics research. Nature 2003; 422:835-847.
25. SCHORK NJ, FALLIN D, LANCHBURY JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 2000; 58:250-264.
26. FENG Z, ZHANG JT. Protective effect of melatonin on beta-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism. Free Radic Biol Med 2004; 37:1790-1801.
27. PASKALOGLU K, SENER G, AYANGOLU-DULGER G. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur J Pharmacol 2004; 499:345-354.
28. EBISAWA T, KAJIMURA N, UCHIYAMA M et al. Allelic variants of human melatonin Ia receptor: function and prevalence in subjects with circadian rhythm sleep disorders. Biochem Biophys Res Commun 1999; 262:832-837.
29. EBISAWA T, UCHIYAMA M, KAJIMURA N et al. Genetic polymorphisms of human melatonin 1b receptor gene in circadian rhythm sleep disorders and controls. Neurosci Lett 2000; 280:29-32.
30. DUBOCOVICH ML, YUN K, AL-GHOUL WM et al. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 1998; 12:1211-1220.
31. LIU C, WEAVER DR, JIN X et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19:91-102.
32. MORCUENDE JA, MINHAS R, DOLAN L et al. Allelic variants of human melatonin IA receptor in patients with familial adolescent idiopathic scoliosis. Spine 2003; 28:2025-2028.
33. WANG GY, LEE CG, LEE EJ. Genetic variability of aryl-alkylamine-N-acetyl- transferase (AA-NAT) gene and human sleep/wake pattern. Chronobiol Int 2004; 21:229-237.
34. HOHJOH H, TAKASU M, SHISHIKURA K et al. Significant association of the arylalkylamine N-acetyltransferase (AA-NAT) gene with delayed sleep phase syndrome. Neurogenetics 2003; 4:151-153.
35. LECHNER O, DIETRICH H, OLIVEIRA DOS SANTOS A et al. Altered circadian rhythms of the stress hormone and melatonin response in lupus-prone MRL/MP-fas(lpr) mice. J Autoimmun 2000; 14:325-333.
36. WOLLMANN HA, PLEYER U, FRIEDEL S et al. Neuroendocrine alterations in uveitis patients. Graefes Arch Clin Exp Ophthalmol 1994; 232:297-301.
37. TOUITOU Y, LE HOANG P, CLAUSTRAT B et al. Decreased nocturnal plasma melatonin peak in patients with a functional alteration of the retina in relation with uveitis. Neurosci Lett 1986; 70:170-174.